SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will be speaking on two panels, Starting Up Biotechs in the New Normal World and Success in the States: A Guide for Foreign Companies to the Largest Venture Capital Pool in the World, at the Bio 2011 conference in Washington, D.C.
News | 06. 29. 2011
